Medical management of anal intraepithelial neoplasia

Reconstructive Surgery of the Rectum, Anus and Perineum

Volumn , Issue , 2013, Pages 191-199

  Palefsky, Joel ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Anal cancer; Anal intraepithelial neoplasia (AIN); Cervical intraepithelial neoplasia (CIN); High grade anal intraepithelial neoplasia (HGAIN); Human immunodeficiency virus (HIV); Human papillomavirus (HPV)

Indexed keywords

EID: 84930241502     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-1-84882-413-3_17     Document Type: Chapter

References (35)

1. Hoots BE, Palefsky JM, Pimenta JM, Smith JS. Human papillomavirus type distribution in anal cancer and anal intraepithelial lesions. Int J Cancer. 2009;124(10):2375–83.
2. de Sanjose S, Quint WG, Alemany L, Geraets DT, Klaustermeier JE, Lloveras B, et al. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study. Lancet Oncol. 2010;11(11):1048–56.
3. Palefsky JM. Anal cancer prevention in HIV-positive men and women. Curr Opin Oncol. 2009;21(5):433–8.
4. Scholefield JH, Castle MT, Watson NF. Malignant transformation of high-grade anal intraepithelial neoplasia. Br J Surg. 2005;92(9):1133–6.
5. Watson AJ, Smith BB, Whitehead MR, Sykes PH, Frizelle FA. Malignant progression of anal intra-epithelial neoplasia. ANZ J Surg. 2006;76(8):715–7.
6. Berry JM, Palefsky JM, Jay N, Cheng SC, Darragh TM, Chin-Hong PV. Performance characteristics of anal cytology and human papillomavirus testing in patients with high-resolution anoscopy-guided biopsy of high-grade anal intraepithelial neoplasia. Dis Colon Rectum. 2009;52(2):239–47.
7. Nathan M, Hickey N, Mayuranathan L, Vowler SL, Singh N. Treatment of anal human papillomavirus-associated disease: a long term outcome study. Int J STD AIDS. 2008;19(7):445–9.
8. Johnson LG, Madeleine MM, Newcomer LM, Schwartz SM, Daling JR. Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973-2000. Cancer. 2004;101(2):281–8.
9. Daling JR, Weiss NS, Klopfenstein LL, Cochran LE, Chow WH, Daifuku R. Correlates of homosexual behavior and the incidence of anal cancer. JAMA. 1982;247(14):1988–90.
10. Chin-Hong PV, Berry JM, Cheng SC, Catania JA, Da Costa M, Darragh TM, et al.comparison of patient- and clinician-collected anal cytology samples to screen for human papillomavirus-associated anal intraepithelial neoplasia in men who have sex with men. Ann Intern Med. 2008;149(5):300–6.
11. Harris TG, Burk RD, Palefsky JM, Massad LS, Bang JY, Anastos K, et al. Incidence of cervical squamous intraepithelial lesions associated with HIV serostatus, CD4 cell counts, and human papillomavirus test results. JAMA. 2005;293(12):1471–6.
12. Palefsky JM, Holly EA, E firdc JT, Da Costa M, Jay N, Berry JM, et al. Anal intraepithelial neoplasia in the highly active antiretroviral therapy era among HIV-positive men who have sex with men. AIDS. 2005;19(13):1407–14.
13. Piketty C, Selinger-Leneman H, Grabar S, Duvivier C, Bonmarchand M, Abramowitz L, et al. Marked increase in the incidence of invasive anal cancer among HIV-infected patients despite treatment with combination antiretroviral therapy. AIDS. 2008;22(10):1203–11.
14. D’Souza G, Wiley DJ, Li X, Chmiel JS, Margolick JB, Cranston RD, et al. Incidence and epidemiology of anal cancer in the Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr. 2008;48(4):491–9.
15. Patel P, Hanson DL, Sullivan PS, Novak RM, Moorman AC, Tong TC, et al. Incidence of types of cancer among HIV-infected persons compared with the general population in the United States, 1992-2003. Ann Intern Med. 2008;148(10):728–36.
16. Frisch M, Biggar RJ, Goedert JJ. Human papillomavirus-associated cancers in patients with human immunoDeficiency virus infection and acquired immunoDeficiency syndrome. J Natl Cancer Inst. 2000;92(18):1500–10.
17. Rabkin CS, Biggar RJ, Melbye M, Curtis RE. Second primary cancers following anal and cervical carcinoma: evidence of shared etiologic factors. Am J Epidemiol. 1992;136(1):54–8.
18. Patel HS, Silver AR, Northover JM. Anal cancer in renal transplant patients. Int J Colorectal Dis. 2005;22:1–5.
19. Fleshner PR, Chalasani S, Chang GJ, Levien DH, Hyman NH, Buie WD. Practice parameters for anal squamous neoplasms. Dis Colon Rectum. 2008;51(1):2–9.
20. Darragh TM, Winkler B. Anal cancer and cervical cancer screening: key differences. Cancer Cytopathol. 2011;119(1):5–19.
21. Palefsky JM, Holly EA, Hogeboom CJ, Jay N, Berry M, Darragh TM. Anal cytology as a screening tool for anal squamous intraepithelial lesions. J Acquir Immune Defic Syndr. 1997;14:415–22.
22. Vajdic CM, Anderson JS, Hillman RJ, Medley G, Grulich AE. Blind sampling is superior to anoscope guided sampling for screening for anal intraepithelial neoplasia. Sex Transm Infect. 2005;81(5):415–8.
23. Cranston RD, Darragh TM, Holly EA, Jay N, Berry JM, Costa MD, et al. Self-collected versus clinician-collected anal cytology specimens to diagnose anal intraepithelial neoplasia in HIV-positive men. J Acquir Immune Defic Syndr. 2004;36(4):915–20.
24. Lampinen TM, Miller ML, Chan K, Anema A, van Niekerk D, Schilder AJ, et al. Randomized clinical evaluation of self-screening for anal cancer precursors in men who have sex with men. Cytojournal. 2006;3:4.
25. Goldie SJ, Kuntz KM, Weinstein MC, Freedberg KA, Palefsky JM. Cost-effectiveness of screening for anal squamous intraepithelial lesions and anal cancer in human immunoDeficiency virus-negative homosexual and bisexual men. Am J Med. 2000;108(8):634–41.
26. Goldie SJ, Kuntz KM, Weinstein MC, Freedberg KA, Welton ML, Palefsky JM. The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men. JAMA. 1999;281(19):1822–9.
27. Jay N, Holly EA, Berry M, Hogeboom CJ, Darragh TM, Palefsky JM. Colposcopic correlates of anal squamous intraepithelial lesions. Dis Colon Rectum. 1997;40:919–28.
28. Singh JC, Kuohung V, Palefsky JM. Ef ficacy of trichloroacetic acid in the treatment of anal intraepithelial neoplasia in HIV-positive and HIV-negative men who have sex with men. J Acquir Immune Defic Syndr. 2009;52(4):474–9.
29. Kreuter A, Brockmeyer NH, Altmeyer P, Wieland U. Anal intraepithelial neoplasia in HIV infection. German Competence Network HIV/AIDS. J Dtsch Dermatol Ges. 2008;6(11):925–34.
30. Kreuter A, Potthoff A, Brockmeyer NH, Gambichler T, Stucker M, Altmeyer P, et al. Imiquimod leads to a decrease of human papillomavirus DNA and to a sustained clearance of anal intraepithelial neoplasia in HIV-infected men. J Invest Dermatol. 2008;128(8): 2078–83.
31. Fox PA, Nathan M, Francis N, Singh N, Weir J, Dixon G, et al. A double-blind, randomized controlled trial of the use of imiquimod cream for the treatment of anal canal high-grade anal intraepithelial neoplasia in HIV-positive MSM on HAART, with long-term follow- up data including the use of open-label imiquimod. AIDS. 2010;24(15):2331–5.
32. Goldstone SE, Hundert JS, Huyett JW. Infrared coagulator ablation of high-grade anal squamous intraepithelial lesions in HIV-negative males who have sex with males. Dis Colon Rectum. 2007;50(5): 565–75.
33. Stier EA, Goldstone SE, Berry JM, Panther LA, Jay N, Krown SE, et al. Infrared coagulator treatment of high-grade anal dysplasia in HIV-infected individuals: an AIDS malignancy consortium pilot study. J Acquir Immune Defic Syndr. 2008;47(1):56–61.
34. Pineda CE, Berry JM, Jay N, Palefsky JM, Welton ML. High resolution anoscopy targeted surgical destruction of anal highgrade squamous intraepithelial lesions: a ten year experience. Dis Colon Rectum. 2008;51(6):829–35; discussion 835–7. Epub 2008 Mar 25.
35. Richel O, Wieland U, de Vries HJ, Brockmeyer NH, van Noesel C, Potthoff A, Prins JM, Kreuter A. Br J Dermatol. 2010;163(6): 1301–7. doi: 10.1111/j.1365.2010.09982.x. Epub 2010 Nov 4.